ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 2343

$1.09M Total Retail Price of All Prescriptions

Rank: 88 out of 2343

396 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

21% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 15,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 897 760 1 3
SIMVASTATIN 861 691 2 1
METOPROLOL TARTRATE 770 638 3 7
FUROSEMIDE 724 627 4 6
WARFARIN SODIUM 694 501 5 8
LEVOTHYROXINE SODIUM 594 451 6 2
OMEPRAZOLE 487 368 7 4
RISPERIDONE 478 385 8 61
HYDROCODONE-ACETAMINOPHEN 438 235 S3 9 13
POTASSIUM CHLORIDE 341 281 10 18
METFORMIN HCL 309 205 11 9
CITALOPRAM HBR 295 208 12 17
DONEPEZIL HCL 282 251 13 21
KLOR-CON M20 275 214 14 44
GABAPENTIN 263 151 15 16
POLYETHYLENE GLYCOL 3350 252 180 16 54
SERTRALINE HCL 232 164 17 20
AMLODIPINE BESYLATE 231 168 18 5
TAMSULOSIN HCL 224 193 19 29
FLUTICASONE PROPIONATE 222 159 20 46
MIRTAZAPINE 199 188 21 41
LOSARTAN POTASSIUM 197 176 22 19
CLOPIDOGREL 191 162 23 26
ATENOLOL 178 178 24 12
IPRATROPIUM-ALBUTEROL 169 102 25 99
PLAVIX 167 147 26 38
DIGOXIN 165 154 27 35
NAMENDA 164 164 28 36
FENTANYL 156 99 S2 29 69
FINASTERIDE 148 138 30 80
OLANZAPINE 148 108 30 121
OXYCODONE-ACETAMINOPHEN 145 88 S2 32 49
ATORVASTATIN CALCIUM 145 121 32 10
LEVOFLOXACIN 144 115 34 106
NOVOLOG 137 94 35 110
CLONIDINE HCL 133 111 36 70
DIVALPROEX SODIUM 131 83 37 105
QUETIAPINE FUMARATE 131 125 37 77
ALENDRONATE SODIUM 126 114 39 28
RANITIDINE HCL 122 89 40 43
CARVEDILOL 120 76 41 27
LANTUS 118 83 42 51
CARBIDOPA-LEVODOPA 117 108 43 85
ZOLPIDEM TARTRATE 114 74 44 24
METOPROLOL SUCCINATE 108 77 45 14
ABILIFY 108 61 45 159
HALOPERIDOL 107 100 47 229
ALLOPURINOL 106 81 48 31
BENZTROPINE MESYLATE 106 79 R 48 224
METOCLOPRAMIDE HCL 105 93 50 168
LEVETIRACETAM 104 69 51 104
SEROQUEL 104 97 51 171
ISOSORBIDE MONONITRATE ER 102 82 53 32
PREDNISONE 102 61 53 37
AZITHROMYCIN 99 71 55 39
GLIPIZIDE 98 85 56 56
VENLAFAXINE HCL ER 96 96 57 87
JANUVIA 95 85 58 50
CARBAMAZEPINE 94 64 59 206
HYDROCHLOROTHIAZIDE 86 67 60 11
NYSTOP 86 46 60 196
PANTOPRAZOLE SODIUM 85 58 62 22
CYMBALTA 83 51 63 74
BUMETANIDE 76 40 64 91
CLOZAPINE 75 49 65 245
PERPHENAZINE 72 11 66 417
PAROXETINE HCL 71 48 67 66
ADVAIR DISKUS 69 27 68 34
ROPINIROLE HCL 68 62 69 124
TRAMADOL HCL 67 43 70 25
CRESTOR 67 47 70 30
TRIAMCINOLONE ACETONIDE 67 25 70 137
GLIPIZIDE ER 66 61 73 115
SPIRIVA 65 40 74 48
TRAZODONE HCL 64 64 75 53
VENLAFAXINE HCL 64 64 75 252
CLOTRIMAZOLE-BETAMETHASONE 63 42 77 127
COLCRYS 62 45 78 166
FLOVENT HFA 60 56 79 213
NITROSTAT 60 46 79 164
DILTIAZEM 24HR CD 60 46 79 83
DILTIAZEM 24HR ER 59 52 82 76
PRAVASTATIN SODIUM 59 51 82 15
FAMOTIDINE 58 55 84 60
AMIODARONE HCL 57 47 85 158
DIVALPROEX SODIUM ER 53 24 86 267
LOVASTATIN 53 41 86 47
CEPHALEXIN 53 38 86 111
AMOXICILLIN 52 43 89 118
BACLOFEN 51 14 90 161
VENTOLIN HFA 51 27 90 79
CIPROFLOXACIN HCL 50 39 92 72
LACTULOSE 50 46 92 139
OXYCODONE HCL 50 17 S2 92 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.